Influence of monoolein on progesterone transdermal delivery
abstract This work aimed to investigate in vitro the influence of monoolein (MO) on progesterone (PG) transdermal delivery and skin retention. Information about the role of MO as an absorption enhancer for lipophilic molecules can help on innovative product development capable of delivering the hormone through the skin in a consistent manner, improving transdermal therapy of hormonal replacement. MO was dispersed in propylene glycol under heat at concentrations of 0% (control), 5% w/w, 10% w/w and 20% w/w. Then, 0.6% of PG (w/w) was added to each formulation. Permeation profile of the hormone was determined in vitro for 48 h using porcine skin in Franz diffusion cells. PG permeation doubled when 5% (w/w) of MO was present in formulation in comparison to both the control and higher MO concentrations (10% and 20% w/w). An equal trend was observed for PG retention in stratum corneum (SC) and reminiscent skin (E+D). PG release rates from the MO formulations, investigated using cellulose membranes, revealed that concentrations of MO higher than 5% (w/w) hindered PG release, which indeed negatively reflected on the hormone permeation through the skin. In conclusion, this work demonstrated the feasibility of MO addition (at 5% w/w) in formulations as a simple method to increase transdermal PG delivery for therapies of hormonal replacement. In contrast, higher MO concentrations (from 10% to 20% w/w) can control active release, and this approach could be extrapolated to other lipophilic, low-molecular-weight molecules.
Main Authors: | , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
2015
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502015000400923 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1984-82502015000400923 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1984-825020150004009232016-03-30Influence of monoolein on progesterone transdermal deliveryQuintão,Wanessa de Souza CardosoMatos,Breno NoronhaReis,Thaiene AvilaBarreto,Lívia Cristina de SáGratieri,TaísGelfuso,Guilherme Msrtins Monoolein/influence/transdermal therapy Progesterone/transdermal delivery Progesterone/skin retention Hormonal replacement/transdermal therapy Skin permeation. abstract This work aimed to investigate in vitro the influence of monoolein (MO) on progesterone (PG) transdermal delivery and skin retention. Information about the role of MO as an absorption enhancer for lipophilic molecules can help on innovative product development capable of delivering the hormone through the skin in a consistent manner, improving transdermal therapy of hormonal replacement. MO was dispersed in propylene glycol under heat at concentrations of 0% (control), 5% w/w, 10% w/w and 20% w/w. Then, 0.6% of PG (w/w) was added to each formulation. Permeation profile of the hormone was determined in vitro for 48 h using porcine skin in Franz diffusion cells. PG permeation doubled when 5% (w/w) of MO was present in formulation in comparison to both the control and higher MO concentrations (10% and 20% w/w). An equal trend was observed for PG retention in stratum corneum (SC) and reminiscent skin (E+D). PG release rates from the MO formulations, investigated using cellulose membranes, revealed that concentrations of MO higher than 5% (w/w) hindered PG release, which indeed negatively reflected on the hormone permeation through the skin. In conclusion, this work demonstrated the feasibility of MO addition (at 5% w/w) in formulations as a simple method to increase transdermal PG delivery for therapies of hormonal replacement. In contrast, higher MO concentrations (from 10% to 20% w/w) can control active release, and this approach could be extrapolated to other lipophilic, low-molecular-weight molecules.info:eu-repo/semantics/openAccessUniversidade de São Paulo, Faculdade de Ciências FarmacêuticasBrazilian Journal of Pharmaceutical Sciences v.51 n.4 20152015-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502015000400923en10.1590/S1984-82502015000400018 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Quintão,Wanessa de Souza Cardoso Matos,Breno Noronha Reis,Thaiene Avila Barreto,Lívia Cristina de Sá Gratieri,Taís Gelfuso,Guilherme Msrtins |
spellingShingle |
Quintão,Wanessa de Souza Cardoso Matos,Breno Noronha Reis,Thaiene Avila Barreto,Lívia Cristina de Sá Gratieri,Taís Gelfuso,Guilherme Msrtins Influence of monoolein on progesterone transdermal delivery |
author_facet |
Quintão,Wanessa de Souza Cardoso Matos,Breno Noronha Reis,Thaiene Avila Barreto,Lívia Cristina de Sá Gratieri,Taís Gelfuso,Guilherme Msrtins |
author_sort |
Quintão,Wanessa de Souza Cardoso |
title |
Influence of monoolein on progesterone transdermal delivery |
title_short |
Influence of monoolein on progesterone transdermal delivery |
title_full |
Influence of monoolein on progesterone transdermal delivery |
title_fullStr |
Influence of monoolein on progesterone transdermal delivery |
title_full_unstemmed |
Influence of monoolein on progesterone transdermal delivery |
title_sort |
influence of monoolein on progesterone transdermal delivery |
description |
abstract This work aimed to investigate in vitro the influence of monoolein (MO) on progesterone (PG) transdermal delivery and skin retention. Information about the role of MO as an absorption enhancer for lipophilic molecules can help on innovative product development capable of delivering the hormone through the skin in a consistent manner, improving transdermal therapy of hormonal replacement. MO was dispersed in propylene glycol under heat at concentrations of 0% (control), 5% w/w, 10% w/w and 20% w/w. Then, 0.6% of PG (w/w) was added to each formulation. Permeation profile of the hormone was determined in vitro for 48 h using porcine skin in Franz diffusion cells. PG permeation doubled when 5% (w/w) of MO was present in formulation in comparison to both the control and higher MO concentrations (10% and 20% w/w). An equal trend was observed for PG retention in stratum corneum (SC) and reminiscent skin (E+D). PG release rates from the MO formulations, investigated using cellulose membranes, revealed that concentrations of MO higher than 5% (w/w) hindered PG release, which indeed negatively reflected on the hormone permeation through the skin. In conclusion, this work demonstrated the feasibility of MO addition (at 5% w/w) in formulations as a simple method to increase transdermal PG delivery for therapies of hormonal replacement. In contrast, higher MO concentrations (from 10% to 20% w/w) can control active release, and this approach could be extrapolated to other lipophilic, low-molecular-weight molecules. |
publisher |
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas |
publishDate |
2015 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502015000400923 |
work_keys_str_mv |
AT quintaowanessadesouzacardoso influenceofmonooleinonprogesteronetransdermaldelivery AT matosbrenonoronha influenceofmonooleinonprogesteronetransdermaldelivery AT reisthaieneavila influenceofmonooleinonprogesteronetransdermaldelivery AT barretoliviacristinadesa influenceofmonooleinonprogesteronetransdermaldelivery AT gratieritais influenceofmonooleinonprogesteronetransdermaldelivery AT gelfusoguilhermemsrtins influenceofmonooleinonprogesteronetransdermaldelivery |
_version_ |
1756437797854511104 |